Page last updated: 2024-10-31

metyrapone and Hyperactivity, Motor

metyrapone has been researched along with Hyperactivity, Motor in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research Excerpts

ExcerptRelevanceReference
" In the olfactory bulbectomized rat model of depression, chronic administration (14 days) of metyrapone (50 mg/kg b."1.30Metyrapone displays antidepressant-like properties in preclinical paradigms. ( Cryan, JF; Harkin, A; Healy, DG; Kelly, JP; Leonard, BE, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Healy, DG1
Harkin, A1
Cryan, JF1
Kelly, JP1
Leonard, BE1

Other Studies

1 other study available for metyrapone and Hyperactivity, Motor

ArticleYear
Metyrapone displays antidepressant-like properties in preclinical paradigms.
    Psychopharmacology, 1999, Volume: 145, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Antidepressive Agents, Tricy

1999